Chart calendar Lotus Pharmaceutical Co., Ltd.

a9bfe996afd873ad.78oFg6uBGfFEmYx9xQbLehgeTfIRdugeX-OduXvfuoA.25NyyOXZS6IG_-kbqkSRDVd7PJVhPdhsDLn29x6R2drdgHTv5ehKlSis3Q~5550125a4ea3bafb36c75e78d84a83e5

Upcoming events on Lotus Pharmaceutical Co., Ltd.

2026-06-15

Annual General Meeting

09:00 pm

Past events on Lotus Pharmaceutical Co., Ltd.

2026-03-17

Earnings presentation

Day
2025-11-24

Earnings presentation

Day
2025-08-14

Earnings presentation

Day
2025-06-25

Annual General Meeting

09:00 pm
2025-05-21

Earnings presentation

02:00 am
2025-05-21

Earnings presentation

03:30 am

Past dividends on Lotus Pharmaceutical Co., Ltd.

2025-08-11

Ex-dividend date - 5.77859 TWD

12:00 am

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027
Net sales
Million TWD
Released
Forecast
Spread
16 958
17 025
-0.39%
18 584
18 469
0.62%
20 509
20 088
2.1%

32 943


35 325

EBITDA
Million TWD
Released
Forecast
Spread
6 114
6 401
-4.49%
7 303
6 934
5.33%
7 440
7 603
-2.14%

9 568


10 698

EBIT
Million TWD
Released
Forecast
Spread
4 903
5 407
-9.33%
6 020
6 133
-1.84%
5 904
6 220
-5.07%

8 698


9 013

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
5 103
5 139
-0.71%
6 360
5 973
6.48%
5 718
6 260
-8.65%

5 538


6 470

Net income
Million TWD
Released
Forecast
Spread
4 106
4 090
0.37%
5 066
4 810
5.3%
4 720
5 081
-7.11%

4 240


4 872

EPS
TWD
Released
Forecast
Spread
15,7
15,6
1.05%
19,4
18,3
5.93%
18,1
19,3
-5.93%

16,1


18,7

Announcement Date15/03/2407/03/2514/03/26-

Quarterly results

Fiscal PeriodDecember 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million TWD
Released
Forecast
Spread
4 743
5 004
-5.21%
5 234
5 217
0.32%
4 409
4 266
3.36%
4 730
4 456
6.16%
4 747
5 168
-8.15%
4 771
4 731
0.84%
6 262
5 523
13.39%
8 644
7 483
15.53%

8 451


8 576


8 433

EBITDA
Million TWD
Released
Forecast
Spread
1 944
2 268
-14.27%
2 439
2 306
5.78%
1 347
1 820
-25.97%
2 066
2 217
-6.8%
1 871
2 638
-29.07%
1 559
1 945
-19.84%
1 943
2 385
-18.53%
2 591
2 517
2.93%

2 685


2 732


2 695

EBIT
Million TWD
Released
Forecast
Spread
1 633
1 827
-10.63%
2 112
2 052
2.92%
1 019
1 147
-11.13%
1 715
1 348
27.25%
1 504
1 840
-18.28%
1 193
1 501
-20.55%
1 493
1 764
-15.36%
1 959
1 709
14.66%

2 303


2 347


2 183

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
1 661
1 776
-6.48%
1 898
2 018
-5.97%
1 494
1 113
34.23%
1 742
1 295
34.49%
827
1 727
-52.09%
1 832
1 480
23.8%
1 316
1 918
-31.37%
726
958
-24.2%

1 552


1 596


1 433

Net income
Million TWD
Released
Forecast
Spread
1 332
1 398
-4.75%
1 565
1 603
-2.38%
1 133
883
28.22%
1 435
1 028
39.56%
728
1 384
-47.38%
1 435
1 183
21.28%
1 122
1 535
-26.91%
567
719
-21.15%

1 194


1 228


1 099

EPS
TWD
Released
Forecast
Spread
5,09
5,32
-4.29%
5,98
6,09
-1.81%
4,32
3,35
29.15%
5,47
3,90
40.26%
2,79
5,23
-46.69%
5,53
4,50
22.96%
4,32
5,83
-25.94%
2,00
2,75
-27.27%

4,54


4,66


4,18

Announcement Date08/08/2407/11/2407/03/2509/05/2513/08/2514/11/2514/03/2612/05/26---
2026-05-18

Information meeting

Day
Today

Information meeting

09:00 am
2026-05-18

Présentation aux Actionnaires / Analystes

08:30 pm
2026-05-18

Board of Directors Meeting

Day
2026-05-18

Board of Directors Meeting

Day
2026-05-18

Annual General Meeting

Day
2026-05-18

Earnings presentation

09:30 pm
2026-05-18

Annual General Meeting

Day
2026-05-18

Board of Directors Meeting

Day
2026-05-18

Annual General Meeting

Day

Past sector events for Lotus Pharmaceutical Co., Ltd.

Today

Ex-dividend date - 0.71 EUR

12:00 am
Today

Ex-dividend date - 0.28 EUR

12:00 am
Today

Annual General Meeting

02:00 am
Today

Annual General Meeting

02:00 am
Today

Annual General Meeting

01:30 am
Today

Earnings presentation

03:00 am
Today

Earnings presentation

02:00 am
Today

Earnings presentation

02:30 am
Today

Annual General Meeting

02:00 am
Today

Annual General Meeting

02:30 am

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1795 Stock
  4. Calendar Lotus Pharmaceutical Co., Ltd.